Pharma Mirror

FEBRUARY 18, 2021

A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16.

Immunization 52

Immunization Immunity Vaccines 52

pharmaphorum

JULY 26, 2022

For years, the promise of therapeutic cancer vaccines has intrigued researchers working in the oncology space. The concept of pre-emptively training the immune system to increase the frequencies of tumour-reactive T cells could be game-changing for cancer patients worldwide. And for good reason.

Vaccines 52

Vaccines Immunization Immunity 52

pharmaphorum

JANUARY 21, 2021

While restrictions on travel could prevent coronavirus transmission in the short term, digital passports showing COVID-negative and vaccination status may help reopen airports and other badly hit areas of the economy, reports Richard Staines. But could digital immunity passports be the answer?

Vaccines 85

Vaccines Immunization Immunity Hospitals 85

Pharma Mirror

OCTOBER 16, 2023

The first mRNA drug (BNT162b2 vaccine) was granted emergency use authorization by the FDA in December 2020 and approved for marketing in August 2021. The first mRNA drug (BNT162b2 vaccine) was granted emergency use authorization by the FDA in December 2020 and approved for marketing in August 2021.

Immunization 52

Immunization Immunity Vaccines 52

pharmaphorum

DECEMBER 23, 2022

In the last few years, the first generation of cell therapies has offered a powerful new way of treating blood cancers, with CAR-T technology reprogramming patients’ immune system to fight cancer. The post After a slow start for expensive CAR-T therapies, drug developers revisit oral therapies for blood cancer appeared first on.

Drug Development 52

Drug Development Immunization Immunity Hospitals 52

PharmaShots

MARCH 9, 2023

Birthplace: Belén was born in Almansa (Spain) Additional Information: Merck became a significant international participant in immunology, oncology, and immune oncology under her leadership of the Healthcare business. Designation: Global Head Previous company: Merck Global Vaccines (2 yrs. and Banco Bilbao Vizcaya Argentaria S.A

Clinical Pharmacology 40

Clinical Pharmacology Immunization Immunity Pharmaceutical Companies 40

pharmaphorum

AUGUST 13, 2020

New York Magazine , the New York Times and The Economist amongst many other news organisations knocked down their paywalls for COVID-19-related coverage to keep readers informed in a rapidly changing and often confusing environment. Think you need to build manufacturing of a vaccine before you know what’s working.

Health and Personal Care Stores 112

Health and Personal Care Stores Vaccines Communication Diabetes 112